Abstract:The investigation explores 2,3‐dihydroxybenzoyl hydrazine derivative ligands as urease inhibitors, utilizing molecular docking, density functional theory calculations, and molecular dynamics simulations. Key descriptors for inhibitory activity include the HOMO‐LUMO energy gap, dipole moment, and electrostatic potential. Ligand (Z)‐N′‐(3‐aminobenzylidene)‐2,3‐dihydroxybenzohydrazide shows the highest efficacy, suggesting the design of ligands forming additional hydrogen bonds to enhance inhibition. This investigation focuses on a suite of 2,3‐dihydroxybenzoyl hydrazine derivative ligands, examining their viability as urease activity inhibitors and delving into their operative mechanisms. Utilizing molecular docking approaches, the binding patterns and interactive loci of 2,3‐dihydroxybenzoyl hydrazine derivatives with urease were elucidated. The origin of the binding forces between the ligands and urease, along with pertinent descriptors, were scrutinized through an amalgamation of density functional theory calculations and molecular dynamics simulations. The findings indicate that the HOMO‐LUMO energy gap, the dipole moment, and the electrostatic potential serve as robust descriptors of the inhibitory activity exhibited by 2,3‐dihydroxybenzoyl hydrazine derivative ligands against urease. The ligand designated BH‐k emerged as the most efficacious urease inhibitor, with critical hydrogen bonds forming between it and the residues His409, Ala636, and Asp633, in addition to hydrophobic interactions with Arg439. The design of ligands capable of establishing additional hydrogen bonds constitutes an effective strategy to amplify inhibitory efficacy. The results of this research aspire to lay a theoretical foundation for the advancement of novel urease inhibitor designs to counteract health issues emanating from aberrant urease activity.

Synthesis, Molecular Docking, and Inhibitory Activity of a Ni Schiff-base Complex Against Urease

Synthesis, Molecular Docking, and Activity of Schiff-base Copper(ii) Complex with N-n-butylsalicylaldiminate As Helicobacter Pylori Urease Inhibitor

Synthesis, Inhibitory Activity and Molecular Docking Studies of Two Cu(II) Complexes Against Helicobacter Pylori Urease.

Synthesis, Structures and Urease Inhibition Studies of Copper(ii) and Nickel(ii) Complexes with Bidentate N,O-donor Schiff Base Ligands.

Synthesis, Molecular Docking and Biological Evaluation of Schiff Base Transition Metal Complexes As Potential Urease Inhibitors

Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

Synthesis, Structures and Helicobacter Pylori Urease Inhibitory Activity of Copper(ii) Complexes with Tridentate Aroylhydrazone Ligands.

The synthesis, structure and activity evaluation of secnidazole derivatives as helicobacter pylori urease inhibitors

Exploration of thiazine Schiff bases as promising urease inhibitors: Design, synthesis, enzyme inhibition, kinetic analysis, ADME/T evaluation, and molecular docking studies

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.

Synthesis, Characterization and Crystal Structures of Schiff Base Copper Complexes with Urease Inhibitory Activity

Synthesis, Structures and Urease Inhibitory Activity of Cobalt(iii) Complexes with Schiff Bases.

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

The Synthesis, Structure and Activity Evaluation of Pyrogallol and Catechol Derivatives As Helicobacter Pylori Urease Inhibitors

3-Arylpropionylhydroxamic Acid Derivatives As Helicobacter Pylori Urease Inhibitors: Synthesis, Molecular Docking and Biological Evaluation

New Method for the Synthesis of A Mononucleating Cyclic Peptide Ligand, Crystal Structures of Its Ni, Zn, Cu, and Co Complexes, and Their Inhibitory Bioactivity Against Urease

Molecular Docking and Molecular Dynamics Simulations of the Urease Inhibitory Activity of 2,3‐Dihydroxybenzohydrazide Derivatives

Synthesis, Molecular Docking and Kinetic Properties of Β-Hydroxy-β-phenylpropionyl-hydroxamic Acids As Helicobacter Pylori Urease Inhibitors

Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.